Managing incidental pancreatic cystic neoplasms with integrated molecular pathology is a cost-effective strategy
about
Influence of integrated molecular pathology test results on real-world management decisions for patients with pancreatic cysts: analysis of data from a national registry cohortNovel investigative modalities for evaluation of pancreatic cystic lesions: Does increased diagnostic accuracy justify the high costs?
P2860
Managing incidental pancreatic cystic neoplasms with integrated molecular pathology is a cost-effective strategy
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Managing incidental pancreatic ...... y is a cost-effective strategy
@ast
Managing incidental pancreatic ...... y is a cost-effective strategy
@en
Managing incidental pancreatic ...... y is a cost-effective strategy
@nl
type
label
Managing incidental pancreatic ...... y is a cost-effective strategy
@ast
Managing incidental pancreatic ...... y is a cost-effective strategy
@en
Managing incidental pancreatic ...... y is a cost-effective strategy
@nl
prefLabel
Managing incidental pancreatic ...... y is a cost-effective strategy
@ast
Managing incidental pancreatic ...... y is a cost-effective strategy
@en
Managing incidental pancreatic ...... y is a cost-effective strategy
@nl
P2093
P2860
P356
P1476
Managing incidental pancreatic ...... y is a cost-effective strategy
@en
P2093
Ananya Das
Dennis M Smith
Eric Ellsworth
Girish Mishra
Mankanwal Sachdev
William Brugge
P2860
P304
P356
10.1055/S-0034-1392016
P407
P577
2015-06-26T00:00:00Z